Recently, influenza A has entered an epidemic period, and the supply of the new anti-influenza drug “Sufuda” is tight in some pharmacies. In response, Roche said during the press conference that the company attaches great importance to “Sufuda” insurance and supply work in the Chinese market during the 2024-2025 influenza season. Currently, the global production capacity of “Sufuda” is skewed towards the Chinese market. At this stage, there is sufficient supply of “Sufuda” in the Chinese market. The company has achieved access to about 7,000 hospitals across the country, and is working with partners to provide stable supply to various offline pharmacy chains. In addition, using internet hospitals, patients can also purchase “Sufuda” on online platforms such as JD, Meituan, Ali, and Dingdang with a prescription.

Recently, influenza A has entered an epidemic period, and the supply of the new anti-influenza drug “Sufuda” is tight in some pharmacies. In response, Roche said during the press release that the company attaches great importance to “Sufuda” insurance and supply work in the Chinese market during the 2024-2025 influenza season. Currently, the global production capacity of “Sufuda” is skewed towards the Chinese market. At this stage, there is sufficient supply of “Sufuda” in the Chinese market. The company has achieved access to about 7,000 hospitals across the country, and is working with partners to provide stable supply to various offline pharmacy chains. In addition, using internet hospitals, patients can also purchase “Sufuda” on online platforms such as JD, Meituan, Ali, and Dingdang with a prescription.